Quercetin decreases the expression of ErbB2 and ErbB3 proteins in HT-29 human colon cancer cells.

[1]  J. Kuhnau.  The flavonoids. A class of semi-essential food components: their role in human nutrition. , 1976 .

[2]  D. Salomon,et al.  Differential expression of epidermal growth factor-related proteins in human colorectal tumors. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[3]  G. Wong,et al.  Quercetin and rutin as inhibitors of azoxymethanol-induced colonic neoplasia. , 1991, Carcinogenesis.

[4]  M. Raff,et al.  Social controls on cell survival and cell death , 1992, Nature.

[5]  Masahiko S. Satoh,et al.  Role of poly(ADP-ribose) formation in DNA repair , 1992, Nature.

[6]  Gwyn T. Williams,et al.  Molecular regulation of apoptosis: Genetic controls on cell death , 1993, Cell.

[7]  G. Wong,et al.  The effect of dietary quercetin and rutin on AOM-induced acute colonic epithelial abnormalities in mice fed a high-fat diet. , 1993, Nutrition and cancer.

[8]  D Kromhout,et al.  Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands. , 1993, Nutrition and cancer.

[9]  S. Korsmeyer,et al.  Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death , 1993, Cell.

[10]  John Calvin Reed.  Bcl-2 and the regulation of programmed cell death , 1994, The Journal of cell biology.

[11]  Patrick R. Griffin,et al.  Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis , 1995, Nature.

[12]  V. Steele,et al.  Effects of the phytochemicals, curcumin and quercetin, upon azoxymethane-induced colon cancer and 7,12-dimethylbenz[a]anthracene-induced mammary cancer in rats. , 1996, Carcinogenesis.

[13]  C. Rémésy,et al.  Comparative effects of flavonoids on the growth, viability and metabolism of a colonic adenocarcinoma cell line (HT29 cells). , 1996, Cancer letters.

[14]  D. Kerr,et al.  Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[15]  S. Kuo.  Antiproliferative potency of structurally distinct dietary flavonoids on human colon cancer cells. , 1996, Cancer letters.

[16]  C. L. Bird,et al.  Relation of vegetable, fruit, and grain consumption to colorectal adenomatous polyps. , 1996, American journal of epidemiology.

[17]  David R. Kaplan,et al.  Regulation of Neuronal Survival by the Serine-Threonine Protein Kinase Akt , 1997, Science.

[18]  K. Pavelić,et al.  The expression of p185(HER-2/neu) correlates with the stage of disease and survival in colorectal cancer. , 1997, Gastroenterology.

[19]  P. Hollman,et al.  Absorption, metabolism and health effects of dietary flavonoids in man. , 1997, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[20]  John Calvin Reed.  Double identity for proteins of the Bcl-2 family , 1997, Nature.

[21]  S. R. Datta,et al.  Akt Phosphorylation of BAD Couples Survival Signals to the Cell-Intrinsic Death Machinery , 1997, Cell.

[22]  J. Woodgett,et al.  Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation. , 1998, The Biochemical journal.

[23]  H. Friess,et al.  Increased expression of erbB3 in colorectal cancer is associated with concomitant increase in the level of erbB2. , 1998, Human pathology.

[24]  G. de Murcia,et al.  Importance of Poly(ADP-ribose) Polymerase and Its Cleavage in Apoptosis , 1998, The Journal of Biological Chemistry.

[25]  M B Katan,et al.  Bioavailability and health effects of dietary flavonols in man. , 1998, Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement.

[26]  R. Ebermann,et al.  Quercetin-induced apoptosis in colorectal tumor cells: possible role of EGF receptor signaling. , 1999, Nutrition and cancer.

[27]  John Calvin Reed.  Dysregulation of apoptosis in cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  M. Waterfield,et al.  Signalling through phosphoinositide 3-kinases: the lipids take centre stage. , 1999, Current opinion in cell biology.

[29]  H. Matsui,et al.  Expression of heregulin α, erbB2, and erbB3 and their influences on proliferation of gastric epithelial cells , 1999 .

[30]  E. Kandel,et al.  The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. , 1999, Experimental cell research.

[31]  V. Steele,et al.  Chemoprevention studies of the flavonoids quercetin and rutin in normal and azoxymethane-treated mouse colon. , 2000, Carcinogenesis.

[32]  A. Harłozińska,et al.  Expression of the Tyrosine Kinase Activity Growth Factor Receptors (EGFR, ERB B2, ERB B3) in Colorectal Adenocarcinomas and Adenomas , 2000, Tumor Biology.

[33]  J. Martinou,et al.  Cytochrome c release from mitochondria: all or nothing , 2000, Nature Cell Biology.

[34]  W. May,et al.  Survival function of ERK1/2 as IL-3-activated, staurosporine-resistant Bcl2 kinases. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[35]  D. W. Fry,et al.  CI-1033, a pan-erbB tyrosine kinase inhibitor. , 2001, Seminars in oncology.

[36]  A. Buckley.  Lessons from anticancer research might provide new insights into mechanisms of hormone action , 2001, Trends in Endocrinology & Metabolism.

[37]  D. Iannitti,et al.  Overexpression of the HER-2/ neu Oncogene in Pancreatic Adenocarcinoma , 2001, American journal of clinical oncology.

[38]  D. Hayes,et al.  The role of c-erbB-2 as a predictive factor in breast cancer , 2001, Breast cancer.

[39]  E. Kim,et al.  Synthetic low-calcaemic vitamin D3 analogues inhibit secretion of insulin-like growth factor II and stimulate production of insulin-like growth factor-binding protein-6 in conjunction with growth suppression of HT-29 colon cancer cells , 2001, Molecular and Cellular Endocrinology.

[40]  D. W. Fry,et al.  Anticancer therapy targeting the erbB family of receptor tyrosine kinases. , 2001, Seminars in oncology.

[41]  F. Hamdy,et al.  New therapeutic concepts in prostate cancer , 2001, BJU international.

[42]  E. Kim,et al.  Trans-10,cis-12-conjugated linoleic acid inhibits Caco-2 colon cancer cell growth. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[43]  H. Hara,et al.  Suppression of Intestinal Crypt Cell Proliferation and Aberrant Crypt Foci by Dietary Quercetin in Rats , 2002, Nutrition and cancer.

[44]  J. Willson,et al.  Autocrine heregulin generates growth factor independence and blocks apoptosis in colon cancer cells , 2002, Oncogene.

[45]  K. M. Nicholson,et al.  The protein kinase B/Akt signalling pathway in human malignancy. , 2002, Cellular signalling.

[46]  J. Linseisen,et al.  Fasting plasma concentrations of selected flavonoids as markers of their ordinary dietary intake , 2002, European journal of nutrition.

[47]  P. Dennis,et al.  Activation of the PI3K/Akt pathway and chemotherapeutic resistance. , 2002, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[48]  M. Hung,et al.  Novel targets of Akt, p21(Cipl/WAF1), and MDM2. , 2002, Seminars in oncology.

[49]  A. Tyner,et al.  Conjugated linoleic acid inhibits cell proliferation and ErbB3 signaling in HT-29 human colon cell line. , 2003, American journal of physiology. Gastrointestinal and liver physiology.

[50]  H. Cho,et al.  Conjugated linoleic acid downregulates insulin-like growth factor-I receptor levels in HT-29 human colon cancer cells. , 2003, The Journal of nutrition.

[51]  A. Aro,et al.  Consumption of black currants, lingonberries and bilberries increases serum quercetin concentrations , 2003, European Journal of Clinical Nutrition.